Pharmaceutical Company Sponsored Chemist Leads Attack to Censor Homeopathy Research Study

A chemist funded by a pharmaceutical company head is attacking and attempting to censor a research study on the homeopathic treatment of Attention Deficit Hyperactivity Disorder (ADHD). The study is being done by professors and researchers at the University of Toronto in Canada. The chemist, Joe Schwarcz is funded to attack homeopathy by the head of a pharmaceutical company who also funds other anti homeopathy skeptic groups.

Heather Boon, Dean of the University of Toronto’s Faculty of Pharmacy, responded to the attack by saying, “The study comes after years of consultations and a pilot project that observed patient experiences using homeopathic remedies to treat ADHD. We found that over 60 per cent of the patients improved.”

According to the Toronto Star newspaper, the drug company funded chemist has organized a group of scientists to sign a letter that would censor and stop this research and any research into homeopathy. Homeopathy is the second largest form of medicine in the world and has a 200 year history of safety and efficacy.

The Journal of the American Academy of Child and Adolescent Psychiatry found that the total spending on ADHD is up to $266 billion a year. Sales of prescription drugs for ADHD treatment doubled between 2007 and 2012, going from $4 billion to $9 billion. Homeopathy offers a viable and inexpensive alternative and the University of Toronto study is a scientific validation of this.